Nosa Plugs AB (SE:NOSA)
:NOSA
Want to see SE:NOSA full AI Analyst Report?
Top Page
Nosa Plugs AB
(NOSA)
Select Model
Select Model
Rating:48Neutral
Price Target:
kr0.52
▼(-7.14% Downside)
Action:Reiterated
Date:05/23/26
The score is primarily held back by ongoing losses and negative operating cash flow despite improving revenue and gross margin. Low leverage supports financial stability, but technical indicators remain weak with the price below key moving averages and negative MACD. Valuation is difficult to support given the negative P/E and no dividend yield data.
Positive Factors
Revenue Growth
TTM revenue growth to 27.9M (≈59% YoY) indicates durable product-market fit and expanding distribution. Sustained top-line expansion supports scale economics, improves fixed-cost absorption, and provides a multi-month runway to convert volume growth into operating leverage if cost discipline continues.
Negative Factors
Negative Operating Cash Flow
Persistent negative operating cash flow (-7.3M TTM) shows the core business still consumes cash despite revenue gains. Ongoing cash burn limits self-funding for growth, pressures liquidity and raises the likelihood of dilutive financing or curtailed investment, which can slow strategic initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
TTM revenue growth to 27.9M (≈59% YoY) indicates durable product-market fit and expanding distribution. Sustained top-line expansion supports scale economics, improves fixed-cost absorption, and provides a multi-month runway to convert volume growth into operating leverage if cost discipline continues.
Read all positive factors
Nosa Plugs AB (NOSA) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr136.59M
Dividend YieldN/A
Average Volume (3M)339.93K
Price to Earnings (P/E)―
Beta (1Y)0.20
Revenue Growth59.15%
EPS Growth10.47%
CountrySE
Employees7
SectorServices
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.04
Shares Outstanding260,172,580
10 Day Avg. Volume252,761
30 Day Avg. Volume339,932
Financial Highlights & Ratios
PEG Ratio0.60
Price to Book (P/B)3.50
Price to Sales (P/S)6.02
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)kr44.40M
Nosa Plugs AB Business Overview & Revenue Model
Company Description
Nosa Plugs AB, a medical technology company, manufactures and sells intranasal breathing products primarily in Europe and North America. Its products include NOSA plugs, such as NOSA odor control products for odor protection; NOSA microbial contro...
How the Company Makes Money
NOSA makes money primarily by selling its nasal products (notably nose plugs) to customers through wholesale and retail channels. Revenue is generated when distributors, pharmacies/retailers, and other resellers purchase NOSA’s products for onward...
Nosa Plugs AB Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
74
Positive
Cash Flow
27
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.86M | 23.91M | 16.10M | 10.39M | 6.85M | 5.85M |
| Gross Profit | 3.42M | -8.03M | 11.20M | 6.92M | -13.64M | -6.45M |
| EBITDA | -3.83M | -4.12M | -8.45M | -44.98M | -7.59M | -38.60M |
| Net Income | -8.50M | -8.04M | -10.16M | -46.55M | -17.82M | -58.56M |
Balance Sheet | ||||||
| Total Assets | 63.94M | 64.71M | 20.70M | 33.08M | 21.67M | 40.09M |
| Cash, Cash Equivalents and Short-Term Investments | 16.77M | 17.30M | 4.31M | 1.19M | 2.52M | 10.40M |
| Total Debt | 2.17M | 716.00K | 1.01M | 1.88M | 1.72M | 9.04M |
| Total Liabilities | 24.62M | 23.65M | 4.14M | 6.33M | 3.33M | 980.00K |
| Stockholders Equity | 39.32M | 41.06M | 16.56M | 26.75M | 6.70M | 39.10M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | -14.70M | -18.35M | -5.19M | -16.81M |
| Operating Cash Flow | -7.34M | -6.39M | -10.03M | -17.50M | -5.13M | -6.21M |
| Investing Cash Flow | -12.43M | -12.40M | -4.71M | 14.55M | -61.00K | -52.20M |
| Financing Cash Flow | 31.93M | 31.96M | 17.81M | 1.61M | 5.29M | -119.00K |
Nosa Plugs AB Technical Analysis
Negative
0.56
Price Trends
0.56
Negative
0.57
Negative
0.62
Negative
Market Momentum
-0.01
Positive
44.71
Neutral
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOSA, the sentiment is Negative. The current price of 0.56 is below the 20-day moving average (MA) of 0.58, below the 50-day MA of 0.56, and below the 200-day MA of 0.62, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 44.71 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NOSA.
Nosa Plugs AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | kr134.21M | 35.29 | ― | ― | -12.51% | -59.88% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
53 Neutral | kr529.67M | -2.93 | -253.54% | ― | 41.17% | 29.20% | |
51 Neutral | kr88.86M | -3.95 | ― | ― | ― | -4.00% | |
48 Neutral | kr136.59M | -19.07 | ― | ― | 59.15% | 10.47% | |
45 Neutral | kr322.22M | -7.16 | -27.22% | ― | -14.57% | 16.16% | |
43 Neutral | kr38.13M | -1.63 | -60.56% | ― | 27.31% | 6.31% |
* Services Sector Average
SE:NOSA
Nosa Plugs AB
0.54
-0.31
-36.67%
SE:SCIB
SciBase Holding AB
0.46
0.15
46.96%
SE:LXB
Luxbright AB
0.17
-0.59
-77.79%
SE:BRAIN
BrainCool AB
0.83
-0.76
-47.70%
SE:ARCOMA
Arcoma AB
9.50
-0.12
-1.25%
SE:NEOLA
Neola Medical AB
1.16
-1.40
-54.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.